Gomez J - Search Results

1

Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience.

Labrie F, Dupont A, Cusan L, Gomez J, Emond J, Monfette G. Labrie F, et al. Among authors: gomez j. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):943-50. doi: 10.1016/0960-0760(90)90448-t. J Steroid Biochem Mol Biol. 1990. PMID: 2285608 Clinical Trial.

2

Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.

Gomez JL, Dupont A, Cusan L, Tremblay M, Suburu R, Lemay M, Labrie F. Gomez JL, et al. Am J Med. 1992 May;92(5):465-70. doi: 10.1016/0002-9343(92)90741-s. Am J Med. 1992. PMID: 1349790

3

Serum prostate specific antigen as pre-screening test for prostate cancer.

Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, Emond J. Labrie F, et al. Among authors: gomez jl. J Urol. 1992 Mar;147(3 Pt 2):846-51; discussion 851-2. doi: 10.1016/s0022-5347(17)37402-5. J Urol. 1992. PMID: 1371560

4

Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report.

Gomez JL, Dupont A, Cusan L, Tremblay M, Tremblay M, Labrie F. Gomez JL, et al. Am J Med. 1992 May;92(5):563-6. doi: 10.1016/0002-9343(92)90756-2. Am J Med. 1992. PMID: 1580304

5

Combination therapy with flutamide and castration (orchiectomy or LH-RH agonist) in untreated patients with advanced prostate cancer.

Dupont A, Labrie F, Cusan L, Gomez JL, Tremblay M, Lacourcière Y, Emond J, Monfette G. Dupont A, et al. Among authors: gomez jl. Recent Results Cancer Res. 1992;124:43-54. doi: 10.1007/978-88-470-2186-0_5. Recent Results Cancer Res. 1992. PMID: 1615218 No abstract available.

6

Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.

Dupont A, Cusan L, Gomez JL, Thibeault MM, Tremblay M, Labrie F. Dupont A, et al. Among authors: gomez jl. J Urol. 1991 Oct;146(4):1064-7; discussion 1067-8. doi: 10.1016/s0022-5347(17)38001-1. J Urol. 1991. PMID: 1716697

7

Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamide.

Cusan L, Gomez JL, Dupont A, Diamond P, Lemay M, Moore S, Labrie F. Cusan L, et al. Among authors: gomez jl. Prostate. 1994 May;24(5):257-61. doi: 10.1002/pros.2990240507. Prostate. 1994. PMID: 7513417

8

Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.

Labrie F, Dupont A, Suburu R, Cusan L, Gomez JL, Koutsilieris M, Diamond P, Emond J, Lemay M, Candas B. Labrie F, et al. Among authors: gomez jl. Clin Invest Med. 1993 Dec;16(6):425-39. Clin Invest Med. 1993. PMID: 7516831 Clinical Trial.

9

Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality.

Labrie F, Cusan L, Gomez JL, Diamond P, Candas B. Labrie F, et al. Among authors: gomez jl. J Clin Endocrinol Metab. 1995 Jul;80(7):2002-13. doi: 10.1210/jcem.80.7.7541800. J Clin Endocrinol Metab. 1995. PMID: 7541800 Review.

10

The impact of family history on early detection of prostate cancer.

Narod SA, Dupont A, Cusan L, Diamond P, Gomez JL, Suburu R, Labrie F. Narod SA, et al. Among authors: gomez jl. Nat Med. 1995 Feb;1(2):99-101. doi: 10.1038/nm0295-99. Nat Med. 1995. PMID: 7585019 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,968 results

Search Page

Filters